100 Views

Fortress-owned FTAI debuts IPO

Fortress Transportation and Infrastructure Investors LLC, which owns and acquires transportation-related infrastructure and equipment, has raised $34 million for its IPO after pricing its 20 million shares at $17 per share. The stock began trading Friday on the NYSE under the ticker symbol “FTAI.” Citigroup Global Markets Inc., BofA Merrill Lynch, Barclays Capital Inc, Deutsche Bank Securities Inc and UBS Securities LLC are the lead underwriters. FTAI is owned by Fortress Investment Group.

136 Views

VC-backed Glaukos Corp files for IPO

Laguna Hills, California-based Glaukos Corporation, a developer of treatments for glaucoma, has filed for an IPO. The number of shares that will be sold as well as the IPO’s pricing terms have yet to be set. The company plans on trading the stock on the NYSE under the ticker symbol “GKOS.” J.P. Morgan, BofA Merrill Lynch and Goldman, Sachs & Co are serving as the lead underwriters. Glaukos’ backers include OrbiMed Advisors, Frazier Healthcare Ventures, InterWest Partners, Domain Associates, Fjord Ventures, Montreaux Equity Partners and Versant Ventures

VC-backed Adaptimmune rolls out IPO

UK and Philadelphia-based biotechnology company Adaptimmune Therapeutics plc has debuted its IPO after pricing its 11.25 million shares at $17 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “ADAP.” BofA Merrill Lynch, Cowen and Company and Leerink Partners LLC are serving as the lead underwriters. Adaptimmune’s backers include New Enterprise Associates, OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management and Rock Springs Capital.

198 Views

PE-owned restaurant chain Bojangles sets IPO pricing terms

Restaurant chain Bojangles Inc will be selling 6.25 million shares of its IPO at between $15 and $17 per share. The company will list the stock on the NASDAQ under the ticker symbol “BOJA.” BofA Merrill Lynch, Wells Fargo Securities and Jefferies are serving as the lead underwriters. Bojangles is a portfolio company of Advent International.

135 Views

CCMP-backed Milacron files to go public

Milacron Holdings Corp. has filed to raise up to $100 million via initial public offering. Milacron is a Cincinnati-based plastics processing and industrial fluids company that is owned by CCMP Capital Advisors. Milacron did not disclose the shares it would offer or their price range. BofA Merrill Lynch, Barclays and J.P. Morgan are acting as joint lead book-runners on the IPO.

278 Views

Insight Venture Partners to acquire E2open for about $273 mln

Insight Venture Partners has agreed to buy E2open Inc for about $273 million. BofA Merrill Lynch is serving as financial advisor to E2open on the transaction. Based in Foster City, California, E2open is a provider of cloud-based solutions for collaborative planning and execution across global trading networks.

105 Views

VC-backed Ascendis Pharma goes public

Danish biotech firm Ascendis Pharma has raised $108 million for its IPO after pricing its 6 million shares at $18 per share. The stock begins trading Wednesday on the NASDAQ under the ticker symbol “ASND.” BofA Merrill Lynch and Leerink Partners are serving as the lead underwriters. Ascendis Pharma’s backers include Sofinnova Ventures, OrbiMed, Vivo Capital, Venrock, RA Capital Management and Janus Capital Management.

444 Views

Madison Dearborn Partners to acquire Walgreens Infusion Services

Madison Dearborn Partners has agreed to buy a majority stake in Walgreens Infusion Services, a provider of home and alternate treatment site infusion services. No financial terms were disclosed for the transaction that is expected to close during the second quarter of calendar 2015. BofA Merrill Lynch provided financial advice to Walgreen Co. while Barclays, Deutsche Bank and Goldman Sachs advised MDP.

105 Views

VC-backed Entellus Medical sets IPO pricing terms

According to an amended SEC filing, Entellus Medical is planning on selling 4.375 million shares of its IPO at a price range between $15 and $17 per share. BofA Merrill Lynch and Piper Jaffray are serving as lead underwriters. Entellus will list the IPO on the NASDAQ under the ticker symbol “ENTL.” Based in Plymouth, Minnesota , Entellus Media provides treatment solutions for chronic sinusitis. Its backers include Covidien Ventures, SV Life Sciences, Essex Wodlands, Split Rock Partners and Greenspring Associates.

 

shutterstock_126440948
164 Views

VC-backed small biz lender OnDeck debuts IPO

New York City-based small business lender OnDeck has raised $200 million for its IPO after pricing its 10 million shares at $20 per share. The stock began trading Wednesday on the NYSE under the ticker symbol “ONDK.”

113 Views

American Securities-backed MPG rolls out IPO

Metaldyne Performance Group, which is owned by American Securities, has raised $150 million for its IPO after pricing its 10 million shares at $15 per share. The stock began trading Friday on the NYSE under the ticker symbol “MPG.” BofA Merrill Lynch, Goldman Sachs, Deutsche Bank Securities, Barclays Capital, Credit Suisse Securities (USA) and RBC Capital Markets are the lead underwriters. Headquartered in Plymouth, Michigan, MPG is a provider of powertrain components.

336 Views

Providence to buy stake in RentPath from TPG

Providence Equity Partners has agreed to acquire a stake in RentPath from owner TPG. No financial terms were disclosed. According to terms of the deal, Providence and TPG will own equal shares of RentPath. Moelis was lead financial advisor with support from BofA Merrill Lynch. Headquartered in Norcross, Georgia, RentPath is a search company for apartment and home renters.

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget